Abstract: A method for 3-D block modelling of a resource boundary in a post-blast muckpile to optimize destination delineation for resource control is provided. An in-situ pre-blast model of an ore deposit to be mined, movement data, blast design and explosive loading information, and post-blast topographic data are input in to the memory of a general purpose computer. Using the pre-blast block model, movement data, blast design and explosive loading information, and post-blast topographic data a three-dimensional vector field is generated. The method uses the three-dimensional vector field to move a plurality of centroids of the in-situ block model to populate a three-dimensional post-blast location. Then method optimizes the populated three dimensional post-blast location to determine a plurality of sets of optimal dig boundaries.

Abstract: Methods and compositions to prevent or reduce the effects of neovascular eye disease in a subject are provided, wherein the subject is administered a pharmaceutical composition comprising an inhibitor of protein arginine methyltransferase 5 (PRMT5).

Abstract: Disclosed herein are methods and apparatuses for exposing an organic metal-oxide film to a blanket UV treatment prior to a lithographic patterning operation. A blanket UV treatment may be used to shift a solubility curve of the film, such that a lower EUV dose may be used to pattern the film. Additionally, a blanket UV treatment may be used after development to further cure the film.

Abstract: A method of producing a biofilm-like microorganism-polymer complex, the method comprising the step of exposing, in an aqueous medium, cells of a microorganism to a polymer comprising groups as defined by formula (la) or formula (lb), wherein: Y comprises an imine; and R2 comprises a CI-30 group. A biofilm-like microorganism-polymer complex comprising cells of a microorganism and a polymer comprising groups as defined by formula (la) and/or formula (lb). A method for producing a chemical and/or biological product using the microorganism-polymer complex, and the chemical and/or biological products obtained therefrom. A method of dispersing the microorganism-polymer complex. Polymers of formula (la) and of formula (lb).

Abstract: The exemplified methods and systems (e.g., machine-learned systems) facilitate the use of respiration rate-related features, or parameters, in a model or classifier to estimate metrics associated with the physiological state of a subject, including for the presence or non-presence of a disease, medical condition, or indication of either. The estimated metric may be used to assist a physician or other healthcare provider in diagnosing the presence or non-presence and/or severity and/or localization of diseases, medical conditions, or indication of either or in the treatment of said diseases or indicating conditions. In some cases, such respiration rate-related features are generated from a synthetic respiration waveform that represents, and is used as a proxy to, the true respiration waveform. The synthetic respiration waveform may be used in its own independent diagnostic and/or control applications in some embodiments.

Abstract: Systems and methods for blood flow control are described herein. In some variations, a blood flow control system may comprise a blood flow control device. The blood flow control device may be placed within a body of a patient and may comprise an expandable member and a sensor. The sensor may be configured to measure at least one of a physiologic condition of the patient and a pressure associated with the expandable member. The blood flow control system may include at least one controller communicably coupled to the sensor to: receive data indicative of at least one of the physiologic condition of the patient and the pressure associated with the expandable member from the sensor, compare the received data with target data, identify at least one error based on the comparison, and in response to identifying the error, inhibit at least one function of the blood flow control system.

Abstract: A gaming signage system may include one or more movable displays. One or more movable displays may present first visual effects while the one or more movable displays are in a first configuration in which at least one game feature presentation device is not viewable. In response to a trigger event indication (which may correspond to a base game event), the movable display(s) may move to a second configuration and reveal the game feature presentation device. The game feature presentation device may be used to present a bonus feature and/or to present a different aspect of the base game. Alternatively, at least a portion of a movable display may be hidden when in a first configuration. At least the portion of the movable display(s) may present a bonus feature and/or a different aspect of the base game when in the second configuration.

Abstract: In some embodiments, a light emitting structure comprises a layered semiconductor stack comprising a first set of doped layers, a second layer, a light emitting layer positioned between the first set of doped layers and the second layer, and an electrical contact to the first set of doped layers. The first set of doped layers can comprise a first sub-layer, a second sub-layer, and a third sub-layer, wherein the third sub-layer is adjacent to the light emitting layer. The electrical contact can be coupled to the second sub-layer. The first, second and third sub-layers can be doped n-type, and an electrical conductivity of the second sub-layer can be higher than an electrical conductivity of the first and third sub-layers. The first, second and third sub-layers, and the light emitting layer can each comprise a superlattice. The second layer can comprise a chirped superlattice.

Abstract: Embodiments detect cyberattack campaigns against multiple cloud tenants by analyzing activity data to find sharing anomalies. Data that appears benign in a single tenant's activities may indicate an attack when the same or similar data is also found for additional tenants. Attack detection may depend on activity time frames, on how similar certain activities of different tenants are to one another, on how unusual it is for different tenants to share an activity, and on other factors. Sharing anomaly analysis may utilize hypergeometric probabilities or other statistical measures. Detection avoidance attempts using entity randomization are revealed and thwarted. Authorized vendors may be recognized, mooting anomalousness. Although data from multiple tenants is analyzed together for sharing anomalies while monitoring for attacks, tenant confidentiality and privacy are respected through technical and legal mechanisms. Mitigation is performed in response to an attack indication.

Abstract: Dry development or dry removal of metal-containing extreme ultraviolet radiation (EUV) photoresist is performed in atmospheric conditions or performed in process tools without vacuum equipment. Dry removal of the metal-containing EUV photoresist may be performed under atmospheric pressure or over-atmospheric pressure. Dry removal of the metal-containing EUV photoresist may be performed with exposure to an air environment or with non-oxidizing gases. A process chamber or module may be modified or integrated to perform dry removal of the metal-containing EUV photoresist with baking, wafer cleaning, wafer treatment, or other photoresist processing function. In some embodiments, the process chamber for dry removal of the metal-containing EUV photoresist includes a heating assembly for localized heating of a semiconductor substrate and a movable discharge nozzle for localized gas delivery above the semiconductor substrate.

Abstract: An illustrative example fuel cell component includes a plate with a plurality of flow channels in at least one side of the plate. Each of the flow channels has a length between an inlet and an outlet. Each of the flow channels has a width and a depth, which are transverse to the length. At least some of the flow channels include a portion near the inlet and the width or the depth of the portion is greater than the width or depth along a majority of the length of those flow channels.

Abstract: Systems and methods for Endovascular Perfusion Augmentation for Critical Care (EPACC) are provided. The system may include a catheter having an expandable aortic blood flow regulation device disposed on the distal end of the catheter for placement within an aorta of a patient. The system may also include a catheter controller unit that causes the expandable aortic blood flow regulation device to expand and contract to restrict blood flow through the aorta.

Abstract: A clinical evaluation system and method are disclosed that facilitate the use of one or more conduction deviation features or parameters determined from biophysical signals such as cardiac or biopotentials signals. Conduction derivation features or parameters may include VD conduction derivation features or parameters and/or VD conduction derivation Poincaré features or parameters. The conduction derivation features or parameters can be used in a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a patient, including for the presence or non-presence of a disease, a medical condition, or an indication of either. The estimated metric may be used to assist a physician or other healthcare provider in diagnosing the presence or non-presence and/or severity and/or localization of diseases or conditions or in the treatment of said diseases or conditions.

Abstract: A clinical evaluation system and method are disclosed that facilitate the use of features or parameters extracted from biophysical signals in a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a patient, including for the presence or non-presence of elevated left ventricular end-diastolic pressure (elevated LVEDP), as an example indicator of a disease medical condition that could be assessed by using the system and method described herein.

Abstract: The exemplified methods and systems facilitate the use for diagnostics, monitoring, treatment of one or more wavelet-based features or parameters determined from biophysical signals such as cardiac/biopotential signals and/or photoplethysmography signals that are acquired non-invasively. The wavelet-based features or parameters can be used, in one embodiment, within a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a subject, including for the presence or non-presence of a disease or abnormal condition. Wavelet-based features or parameters may include measures that are derived from extractable properties or geometric characteristics of a spectral image or data of high-power spectral contents or high-coherence in waveform signals of interest in an acquired biophysical signal.

Abstract: The exemplified methods and systems facilitate the configuration and training of a neural network (e.g., a deep neural network, a convolutional neural network (CNN), etc.), or ensemble(s) thereof, with a biophysical signal data set to ascertain estimate for the presence or non-presence of disease or pathology in a subject as well as to assess and/or classify disease or pathology, including for example in some cases the severity of such disease or pathology, in a subject. In the context of the heart, the methods and systems described herein facilitate the configuration and training of a neural network, or ensemble(s) thereof, with a cardiac signal data set to ascertain estimate for the presence or non-presence of coronary artery disease or coronary pathology.

Abstract: Methods for making thin-films on semiconductor substrates, may be patterned using EUV, include: depositing the organometallic polymer-like material onto the surface of the semiconductor substrate, exposing the surface to EUV to form a pattern, and developing the pattern for later transfer to underlying layers. The depositing operations may be performed by chemical vapor deposition (CVD), atomic layer deposition (ALD), and ALD with a CVD component, such as a discontinuous, ALD-like process in which metal precursors and counter-reactants are separated in either time or space.

Abstract: Compounds of the formula (I): wherein A and B together represent an optionally substituted, fused aromatic ring; X can be NRX or CRXRY; if X=NRX then n is 1 or 2 and if X=CRXRY then n is 1; RX is selected from the group consisting of H, optionally substituted C1-20 alkyl, C5-20 aryl, C3-20 heterocyclyl, amido, thioamido, ester, acyl, and sulfonyl groups; RY is selected from H, hydroxy, amino; or RX and RY may together form a spiro-C3-7 cycloalkyl or heterocyclyl group; RC1 and RC2 are both hydrogen, or when X is CRXRY, RC1, RC2, RX and RY, together with the carbon atoms to which they are attached, may form an optionally substituted fused aromatic ring; and R1 is selected from H and halo.

Abstract: Methods for performing endovascular procedures are described herein. The methods may comprise advancing an expandable member of a blood flow control device to a target location in a blood vessel of a patient, and rotating a circular gear positioned at least partially within a housing of a controller via the controller communicably coupled to the blood flow control device. Rotating the circular gear may translate a linear gear of a syringe pump fluidly coupled to the expandable member thereby adjusting a volume of the expandable member. Various blood flow control devices, control systems, and fluid delivery systems are also described herein. The fluid delivery systems may include a pump configured for manual or automated delivery of fluids, or configured to switch between automated and manual modes of delivery. The pump may be a syringe pump that utilizes a rack and pinion system, a motor, and a sensor to track the position and/or movement of a component of the syringe pump during fluid transfer.

Abstract: A gaming signage system may include one or more movable displays. One or more movable displays may present first visual effects while the one or more movable displays are in a first configuration in which at least one game feature presentation device is not viewable. In response to a trigger event indication (which may correspond to a base game event), the movable display(s) may move to a second configuration and reveal the game feature presentation device. The game feature presentation device may be used to present a bonus feature and/or to present a different aspect of the base game. Alternatively, at least a portion of a movable display may be hidden when in a first configuration. At least the portion of the movable display(s) may present a bonus feature and/or a different aspect of the base game when in the second configuration.